Cardinal Health (CAH) Dividend Stock Analysis

Cardinal Health Dividend

(updated 5/04/2018)

The Cardinal Health (CAH) dividend has been paid since 1983 and increased for 21 consecutive years;
qualifying the company as a Dividend Contender.

Price: $53.00
Dividend Yield: 3.5%

Current Annual Dividend: $1.848
Cash Flow From Operations (CFO) Per Share (ttm): $9.26
Free Cash Flow Per Share (ttm): $8.18

Market Capitalization: $17 B
Enterprise Value: $23 B

Dividend Analyzer Checklist

(updated March 2018)

Valuation Score (22/34 points)

Free Cash Flow Yield (ttm):  7.5%  (13/17 points)
EV to EBIT (ttm):  17.8
EV to EBITDA (ttm):  11.7 (9/17 points)
Price to Sales Ratio (ttm): 0.2
Price to Book Value (ttm): 2.9
Price to Earnings Ratio (P/E) (ttm): 18
PE 10:  20

Profitability Score (16/33 points)

Operating Earnings Yield (ttm):  7.7% (11/15 points)
Net Income (ttm): $1823 M
Gross Profit (ttm): $6884 M
Total Assets: $44905 M
Gross Profitability Ratio = GP / Total Assets: 16% (5/18 points)
Cash Return On Invested Capital (CROIC)(tttm): 11%
Return on Invested Capital (ROIC): 12%

Dividend Safety Score (24/33 points)

Dividend Payout Ratio (ttm): 32%
Cash Dividend Payout Ratio (ttm): 35%  (10/12 points)
Net Financial Debt: 8510 M
Total Assets: 42905 M
Net Financial Debt / Total Assets:  20% (8/12 points)
Net Financial Debt to EBITDA (ttm):  316%
Piotroski Score (1-9) (TTM): (6/9 points)

TOTAL POINTS – (62/100) (50 is an average score)

Earnings Report: 2/08/18
Next Earnings Report: 5/01/18

Rankings & Recommendations

(updated March 2018)

Cardinal Health (CAH) is ranked #102 (out of 432) overall and 8 (out of 36) in the Healthcare sector by the Dividend Analyzer.

Type of Investor / Recommendation

Large Diversified Dividend Portfolios /  Should be Considered
Looking For Exposure to Healthcare Sector / Can Be Considered
Deep Value Investors / Watchlist

Portfolio Position Disclosures:
DVB Portfolio Stocks: Long
AAAMP Global Value Portfolio: None
AAAMP Retirement Growth & Income Portfolio:  Long
AAAMP Treasure Trove Twelve Portfolio: None

Company Description

Sector: Health Care
Industry: Medical Distribution

Cardinal Health (CAH) is a healthcare and medical products distributor to 20,000 Pharmacies, 5000 pharmaceutical and medical suppliers, and 1.8 million home healthcare patients. The company manufactures or sources more than 2.5 billion individual consumer healthcare, home medical equipment, and over-the-counter products.

With close to 35,000 employees you might say Cardinal Health is the “everywhere” healthcare company. From the company annual report: “Cardinal Health helps customers reduce costs, increase efficiency, and improve quality, outcomes and access. From hospitals to home and everywhere in between, we serve the entire continuum of care with logistics, business, product and patient solutions”.

SWOT Analysis

Strengths

The massive $300 billion retail pharmaceutical business is only going to grow for the foreseeable future. Distribution operations are controlled by three companies (Cardinal Health, AmerisourceBergen, and McKesson) with 90% market share.

CAH competitive advantages include economies of scale, being a low cost provider (deep pricing discounts from drug manufacturers), and barriers to entry (enormous distribution system).

Weaknesses

The healthcare industry is extremely dynamic. Pressure to lower costs are coming from government, suppliers, retailers, and consumers. Regulations (including increased transparency) and procedures are in constant flux.

This is a business with ultra thin margins. While this keeps new competitors from entering the medical distribution industry, it leaves no room for error or unforeseen changes that disrupt profits.

Opportunities

The 10 years agreement with CVS Caremark to combine generic sourcing operations is an example of how CAH can use its size and expertise to lock in business. Partnerships offer opportunities to improve profit margins and provide lower costs to consumers.

Threats

Large contracts tie large percentages of business to one customer. Contracts lost with Walgreens in 2013 and Express Script in 2012 had a significant impact on business operations. CVS health currently represents over 40% of CAH sales. One word: Amazon.

Disclaimer:
While Arbor Investment Planner has used reasonable efforts to obtain information from reliable sources, we make no representations or warranties as to the accuracy, reliability, or completeness of third-party information presented herein. The sole purpose of this analysis is information. Nothing presented herein is, or is intended to constitute investment advice. Consult your financial advisor before making investment decisions.